Thomson Reuters can provide the knowledge, tools and expertise to help support your drug discovery and development activities, optimize your IP portfolio, identify licensing and partnering opportunities, deliver successful regulatory submissions, keep you in touch with the rapidly-changing pharmaceutical and chemical markets, and make informed, early decisions.

Connect with us on Facebook, LinkedIn, and Twitter

WEBINARS

Systems Pharmacology Approaches to Drug Repositioning

In this webinar, investigators will discuss three related topics focused on the challenges and potential, as well as systems pharmacology methods of drug repositioning. Wednesday, May 30, 11am EST. Register Now

The Next Frontier of Follow-on Biologics

The dynamics of the biosimilars market are unlike those of the small-molecule generics market and require a solid understanding of the market attributes, incentives to compete, regulatory requirements and barriers to market entry for successful competition. Wednesday, June 6, 10am EST. Register Now

NEWS

IP & Science Hosts First PharmaVision Event in China

The theme was "Intelligent Information Accelerates Drug Research and Development" and explored the important role of intelligent information in the Life Sciences research and development process. More than 130 life sciences professionals, including many chief executive officers, attended the event where Life Sciences was able to showcase how its products and services can accelerate pharmaceutical innovation in China. Read More

Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders

The solution provides a series of oncology-based clinical dashboards that provide competitive information that quickly answers common questions in drug development. Read the Press Release

Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes

Partner Ecosystem, a new initiative that provides access to Thomson Reuters Life Sciences information through application-specific solutions developed with third-party partners. Read the Press Release -- Visit Partner Ecosystem

SPOTLIGHT ON... CHRONIC MYLEOID LEUKEMIA

This quarter's Spotlight On… Report focuses on Chronic Myeloid Leukemia. With the advent of targeted therapy, chronic myeloid leukemia has undergone a major transformation from a terminal disease to an essentially manageable chronic condition. Despite significantly improved survival rates, there still remains room for improvement in efficacy, tolerability, and resistance potential. Learn More

Thomson Reuters to Work with Michael J. Fox Foundation to Map the Pathways for Parkinson's Disease

The project aims to identify possible causes of Parkinson's by mapping biological mutations of the Leucine-rich repeat kinase 2 (LRRK2) protein, the most common genetic contributor to the disease discovered to date. The maps will trace the disease's biological pathways to pinpoint relevant biomarkers, which are biological molecules that signal an abnormal process or disease. Read More -- Video -- Learn About MetaCore

Search Our Free Pathway Maps

Signaling pathways are the communication highways inside a cell. Like circuitry in a machine, pathways carry important impulses that control all cell functions. The hunt for new and better medicines truly starts here. Please visit our site, www.pathwaymaps.com, to have a taste of some of the 1,200 proprietary multi-step canonical pathway maps contained in MetaCore™.